We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Gyrus Group to Buy ACMI for $500 Million

By HospiMedica staff writers
Posted on 01 Jul 2005
In a move to enhance the company's competitive position, Gyrus Group PLC (Cardiff, UK) has agreed to acquire ACMI Corp. More...
(Southborough, MA, USA), a large endoscope company focusing on developing products for use in urology and gynecology, for about U.S.$500 million in cash and stock.

ACMI (American Cystoscope Makers, Inc.) is the developer of the world's smallest digital camera and video color sensor, recently introduced for use in urology and gynecology examinations. The company has 900 employees and sells in more than 70 countries around the world. AMCI had sales of $184.7 million in its last financial year.

The acquisition will allow Gyrus to compete with multinational companies in the fields of urology and gynecology and will give the firm an opportunity to expand into general surgery, opening up new markets. ACMI was controlled by Fox Paine & Company (San Francisco, CA, USA), a private equity firm that received the right to appoint one member to the Gyrus board of directors as a result of the sale.

"The value established for ACMI in this transaction, which approximately triples our November 1999 investment, marks a significant milestone for ACMI,” stated Saul Fox, CEO of Fox Paine and chairman of ACMI. "This transaction is the culmination of the efforts of many people both within and affiliated with the company who shared the vision of ACMI as an international leader in the conception, design, manufacture, and distribution of sophisticated medical devices enabling minimally invasive urological and gynecological diagnostic and therapeutic modalities.”




Related Links:
Gyrus
ACMI

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Wound Irrigation Solution
Prontosan®
New
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.